1 / 8

dermatology drugs market

dermatology drugs market<br>

sharmashivani21346
Download Presentation

dermatology drugs market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dermatology Drugs Market Set to Exceed USD 20 Billion by 2016 “Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022”

  2. Dermatology Drugs Market Estimate & Forecast to 2022 • Polaris Market Research assumes that with the expected launch of the potential promising therapies, the market is anticipated to expand in both psoriasis and atopic dermatitis segments. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is due to the increased adoption of high priced biologics. Despite the launch and availability of multiple biologics, only 10% of the patients have access to these treatments and the market continues to remain underpenetrated. • Currently, the dermatology drugs market is highly fragmented but offer several commercial opportunities. There remains significant unmet need for safer and cost-effective treatment options. Psoriasis market was nearly USD 6 billion markets in 2016 due to the existing effective TNF alpha treatments. In Acne, retinoids and antibiotics are the mainstay treatments but what makes this indication lucrative is the promising candidates in the pipeline including Foamix’s FMX-101 and Dermira’s DRM-101. • Polaris Market Research has provided the forecasts of the Global Dermatology Drugs Market from 2016-2022. The major segments which has been investigated in the global market from 2016-2022 are: • Market Analysis by Dermatology Key Indications • Market Analysis by Treatment Class/Marketed Drugs • Market Analysis by Regions

  3. Dermatology Drugs Market Scope Request for sample

  4. Dermatology Drugs Market Estimate & Forecast to 2022 • he Marketed Therapies undertaken in forecast from 2016-2022 are: • etanercept; Enbrel • infliximab; Remicade • adalimumab; Humira • ustekinumab; Stelara • secukinumab; Cosentyx • ixekizumab; Taltz • golimumab; Simponi • brodalumab; Siliq • guselkamab; Tremfya • Topical Drugs • Oral Antibiotics • Access Research Report On Dermatology Drugs Market • TheMajor Indications in Dermatology Therapy area: • Atopic Dermatitis • Psoriasis • Acne • Rosacea

  5. Dermatology Drugs Market Size Request for Sample

  6. Dermatology Drugs Market Study – Engagement Options Buy Now – Click Here! Buy now & have immediate access to premium insights Purchase Report Sections – Click Here! Regional analysis Segmentation analysis Industry outlook Competitive landscape Speak To Analyst – Click Here! Get your doubts clear Schedule a call with our analyst before making any decision Request For Sample Pages – Click Here! Get free sample pages Understand report structure Unmask data for validation

  7. About Us Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to e present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Web: www.polarismarketresearch.com

  8. Thank You! Contact Us : Polaris Market Research30 Wall Street8th Floor, New York City, NY 10005,United States E mail Id: sales@polarismarketresearch.com Phone: +1-646-568-9980

More Related